Categories Earnings, Health Care

Mallinckrodt plc (MNK): Q4 2019 Earnings Snapshot

pharma stocks
Image for representation (Photo by Drew Hays on Unsplash)

—  Mallinckrodt plc (NYSE: MNK) reported fourth-quarter 2019 earnings of $2.40 per share, vs. $2.05 per share expected.

— Q4 net sales fell 3.6% to $804.9 million, vs. $772.5 million expected. The topline was helped by strong performance across hospital products and the Specialty Generics segment.

— Company says it has reached an agreement for a global settlement with a broad-based group of plaintiffs that would resolve all opioid-related claims. It would also take actions to address near-term maturities to strengthen capital structure.

 — MNK shares jumped over 20% immediately following the announcement.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

CRM Earnings: Salesforce Q3 revenue up 8.6%; earnings beat estimates

Customer relationship management platform Salesforce, Inc. (NYSE: CRM) on Wednesday reported stronger-than-expected earnings for the third quarter of fiscal 2026. Revenues increased 8.6%. Adjusted net income increased to $3.25 per

Cloud Growth and AI Demand in focus as Oracle gears up for Q2 earnings

Technology giant Oracle Corporation (NYSE: ORCL) began the new fiscal year on a mixed note, reporting Q1 FY26 results that grew year over year but fell short of market expectations.

Key takeaways from Macy’s (M) Q3 2025 earnings report

Shares of Macy’s, Inc. (NYSE: M) gained over 1% in mid-day trade on Wednesday after falling earlier in the day despite the company delivering better-than-expected results for the third quarter

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top